Literature DB >> 7478532

Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.

J Kagan1, J Stein, R J Babaian, Y S Joe, L L Pisters, A B Glassman, A C von Eschenbach, P Troncoso.   

Abstract

Frequent loss of an allele at specific chromosomal regions implicates these regions as sites of tumor suppressor genes (TSG) that become inactivated during tumor progression. We have studied chromosome 8p allele losses in 32 primary human prostate carcinomas with 16 polymorphic microsatellite sequences. Overall, 22 of 32 (69%) informative specimens showed loss of allele in at least one locus. The most frequent losses of heterozygosity (LOH) occurred at the LPL locus (46%) on chromosome 8p22 and at the D8S360 (45%) and NEFL (43%) loci on chromosome 8p21. Homozygous deletions were detected at the LPL and NEFL loci at 8p22 and 8p21, respectively. The minimal region with frequent LOH and homozygous deletion, around the LPL locus, was restricted between the MSR locus and the D8S258 marker, separated by less than 9 cM. The second region was restricted between markers D8S1128 and D8S131 separated by 12 cM. The results suggest the existence of two chromosome 8p sites for candidate TSGs in prostate cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7478532

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).

Authors:  J A Doll; X Zhu; J Furman; Z Kaleem; C Torres; P A Humphrey; H Donis-Keller
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.

Authors:  J Xu; S L Zheng; G A Hawkins; D A Faith; B Kelly; S D Isaacs; K E Wiley; B Chang ; C M Ewing; P Bujnovszky; J D Carpten; E R Bleecker; P C Walsh; J M Trent; D A Meyers; W B Isaacs
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

3.  Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25.

Authors:  R A McIndoe; J L Stanford; M Gibbs; G P Jarvik; S Brandzel; C L Neal; S Li; J T Gammack; A A Gay; E L Goode; L Hood; E A Ostrander
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

4.  Common genetic variants in NEFL influence gene expression and neuroblastoma risk.

Authors:  Mario Capasso; Sharon Diskin; Flora Cimmino; Giovanni Acierno; Francesca Totaro; Giuseppe Petrosino; Lucia Pezone; Maura Diamond; Lee McDaniel; Hakon Hakonarson; Achille Iolascon; Marcella Devoto; John M Maris
Journal:  Cancer Res       Date:  2014-10-13       Impact factor: 12.701

5.  The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

Authors:  H Ishii; R Baffa; S I Numata; Y Murakumo; S Rattan; H Inoue; M Mori; V Fidanza; H Alder; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Interaction of CSR1 with XIAP reverses inhibition of caspases and accelerates cell death.

Authors:  Zhong-Liang Zheng; Lang-Zhu Tan; Yan P Yu; George Michalopoulos; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-06-08       Impact factor: 4.307

7.  FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.

Authors:  H Ishii; A Vecchione; Y Murakumo; G Baldassarre; S Numata; F Trapasso; H Alder; R Baffa; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 8.  Molecular biology of prostate cancer.

Authors:  X B Shi; P H Gumerlock; R W deVere White
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

9.  Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.

Authors:  Hongyi Yang; Yuhua Song
Journal:  J Mol Model       Date:  2016-03-19       Impact factor: 1.810

10.  Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.

Authors:  Quan-Zhe Cui; Zhong-Ping Tang; Xiu-Peng Zhang; Huan-Yu Zhao; Qian-Ze Dong; Ke Xu; En-Hua Wang
Journal:  J Histochem Cytochem       Date:  2013-06-12       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.